Long-lasting Zyprexa gets FDA nod
Lurasidone Effective in Adult Schizophrenia With Few Adverse Metabolic Effects
INVEGA(R) SUSTENNA(TM) Statistically Similar to RISPERDAL(R) CONSTA(R) Long-Acting Injection
Fanapt(TM) Launches in the United States, January 11 2010
Vanda Pharmaceuticals Enters into an Exclusive License Agreement for the Commercialization and Development of Fanapt(TM) in the
FDA approves Zyprexa in tablet form for schizophrenia and manic treatment
Historical perspective on antipsychotic long-acting injections
NAMI's Survey on Depression: Summary of Findings Gaps & Guideposts
You Tube Video on What is Schizophrenia: by Dr. Ken Duckworth
Latest Industry News
CONSUMERS/FAMILIES
PROFESSIONALS
Home
Feature Article
CMS
Rx Medications
Medical Devices
Treatments
Disorders
Education
Support Groups
Success Stories
Terms of Use
Links
About Us
Contact Us
Coming Soon
